XML 141 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Stock-based Compensation
9 Months Ended 12 Months Ended
Sep. 30, 2025
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]    
Stock-based Compensation
12. Stock-based Compensation
Legacy Kodiak 2018 Equity Incentive Plan
In 2018, the Company adopted its 2018 equity incentive plan (the “2018 Plan”). The Plan provides for the granting of stock-based awards, including stock options and restricted stock to eligible participants, including employees, directors, and service providers. Stock options granted under the 2018 Plan can be in the form of incentive stock options or nonqualified stock options.
2025 Equity Incentive Plan
On September 23, 2025, the Company’s stockholders approved and adopted the Kodiak 2025 Equity Incentive Plan (the “2025 EIP”). The 2025 EIP authorizes the issuance of up to 28,195,000 shares of Kodiak common stock, plus up to 56,100,142 additional shares of Kodiak common stock that may become available from awards granted under the 2018 Plan that are forfeited, cancelled, expired, withheld to cover taxes or exercise prices, or otherwise terminated. The 2025 Plan replaced the 2018 Plan, which expired as to future grants as of the Closing. As of September 30, 2025, no awards were granted under the 2025 EIP.
Beginning in 2026, the 2025 EIP also provides for an annual automatic increase in the share reserve equal to the least of (i) 56,390,000 shares of Kodiak common stock, (ii) 5% of the total number of outstanding shares of Kodiak common stock as of the last day of the preceding fiscal year, or (iii) a lesser number determined by the administrator. Awards that may be granted under the 2025 EIP include stock options, stock appreciation rights, restricted stock, restricted stock units, and performance awards to employees, directors and consultants of Kodiak and employees and consultants.
2025 Employee Stock Purchase Plan
On September 23, 2025, the Company’s stockholders approved and adopted the Kodiak 2025 Employee Stock Purchase Plan (the “ESPP”). The ESPP authorizes the issuance of shares of Kodiak common stock pursuant to purchase rights granted to eligible employees. Under the ESPP, 5,639,000 shares of Kodiak common stock are reserved for future issuance. The purchase price for each share during an offering period will be the lesser of 85% of the fair market value of the share on the purchase date or 85% of the fair market value of the share on the offering date. The offering dates and purchase dates for the ESPP are determined at the discretion of the Company’s board of directors. As of September 30, 2025, the Company had not commenced its ESPP.
The number of shares available for issuance under the ESPP will automatically increase on the first day of each fiscal year beginning with fiscal year 2026, by the least of (i) 11,280,000 shares of Kodiak common stock,
 
 
(ii) 1% of the total number of shares of all classes of Kodiak common stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such lesser number of shares as may be determined by the plan administrator prior to the first day of the applicable fiscal year. Shares issued under the ESPP may be authorized but unissued shares or treasury shares.
Stock Option Activity
Stock option activity under the Company’s equity incentive plan was as follows:
 
    
Options Outstanding
 
    
Number of

Options

(in thousands)
    
Weighted–

Average

Exercise

Price
    
Weighted-

Average

Remaining

Contractual

Life

(in years)
    
Aggregate

Intrinsic

Value

(in thousands)
 
Outstanding as of December 31, 2024
     49,157      $ 0.60        
Granted
     11,308        7.10        
Exercised
     (2,130      0.57        
Forfeited
     (1,902      1.40        
Expired
     (443      0.61        
           
  
 
 
    
 
 
       
Outstanding as of September 30, 2025
     55,990      $ 1.88        7.4      $ 553,256  
  
 
 
    
 
 
       
           
Exercisable as of September 30, 2025
     32,050      $ 0.62        6.3      $ 357,707  
  
 
 
    
 
 
       
           
The aggregate intrinsic value in the above table is calculated as the difference between the exercise price of the underlying stock options and the Company’s fair value of its common stock as of the balance sheet date.
As of September 30, 2025, total unrecognized compensation expense related to unvested options was $
69.2 
million, which the Company expects to recognize over an estimated weighted average period of 2.6 years.
Stock-based Compensation
Total stock-based compensation recorded in the Company’s condensed consolidated statements of operations and comprehensive loss was as follows (in thousands):
 
    
Three Months Ended

September 30,
    
Nine Months Ended
September 30,
 
    
2025
    
2024
    
2025
    
2024
 
Research and development
   $ 2,228      $ 1,029      $ 5,148      $ 2,518  
General and administrative
     2,475        421        3,952        988  
Truck and freight operations
     152        59        329        145  
Sales and marketing
     390        209        707        338  
  
 
 
    
 
 
    
 
 
    
 
 
 
Total stock-based compensation
   $ 5,245      $ 1,718      $ 10,136      $ 3,989  
  
 
 
    
 
 
    
 
 
    
 
 
 
13.
Stock-based Compensation
Equity Incentive Plan
In 2018, the Company adopted its 2018 equity incentive plan (the “2018 Plan”). The Plan provides for the granting of stock-based awards, including stock options and restricted stock to eligible participants, including employees, directors, and service providers. Stock options granted under the 2018 Plan can be in the form of incentive stock options or nonqualified stock options. The number of shares of common stock available for issuance under the 2018 Plan may be increased from time to time by the board of directors. As of December 31, 2024, 2,174,985 shares of the Company’s common stock were available for future grant under the 2018 Plan.
Under the 2018 Plan, stock options may be granted for a contractual term not exceeding 10 years and at an exercise price no less than 100% of the estimated fair value of the shares on the date of grant as determined by management and/or the board of directors. The general vesting term for stock options is four years, with a
one-year
cliff vest and monthly thereafter. Additionally, a stock option granted to a 10% stockholder shall not have an exercise price that is less than 110% of the estimated fair value of the shares on the date of grant as determined by the board of directors, and the term of such option grant shall not exceed five years.
Stock Option Activity
Stock option activity under the Company’s equity incentive plan was as follows:
 
    
Options Outstanding
 
    
Number of
Options
(in thousands)
    
Weighted–

Average
Exercise
Price
    
Weighted-
Average
Remaining
Contractual
Life

(in years)
    
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding as of December 31, 2023
     64,357      $   0.42        
Granted
     18,727        0.31        
Exercised
     (424      0.41        
Forfeited
     (4,780      0.42        
Cancelled
     (2,403      0.45        
Expired
     (1,266      0.39        
  
 
 
          
Outstanding as of December 31, 2024
     74,211      $ 0.39        7.6      $   8,729  
  
 
 
          
Exercisable as of December 31, 2024
     39,510      $ 0.41        6.6      $ 4,146  
  
 
 
          
The aggregate intrinsic value in the above table is calculated as the difference between the exercise price of the underlying stock options and the Company’s estimated fair value of its common stock as of each balance sheet date.
The weighted-average grant-date fair value per share of stock options granted during the years ended December 31, 2024 and 2023 was $0.42 and $0.27 per share, respectively. The total grant-date fair value of stock options that vested during the years ended December 31, 2024 and 2023 was $3.3 million and $1.9 million,
 
 
respectively. As of December 31, 2024, total unrecognized compensation expense related to unvested options was $12.3 million, which the Company expects to recognize over an estimated weighted average period of 2.4 years.
Fair Value of Stock Options
The fair value of stock options granted was estimated at the grant-date using the Black-Scholes option-pricing model using the following assumptions:
 
    
Year Ended December 31,
 
    
 2024 
  
   2023   
 
Expected volatility
   87.0% – 91.9%      59.4
Expected term (in years)
   5.1 – 6.1      6.0  
Risk-free interest rate
   3.6% – 4.3%      4.2
Expected dividend yield
   —       —   
Stock-based Compensation
Total stock-based compensation recorded in the Company’s statements of operations and comprehensive loss was as follows (in thousands):
 
    
Year Ended December 31,
 
    
 2024 
    
 2023 
 
Research and development
   $  3,482      $  3,270  
General and administrative
     1,405        1,658  
Sales and marketing
     454        289  
Truck and freight operations
     209        182  
  
 
 
    
 
 
 
Total stock-based compensation
   $ 5,550      $ 5,399  
  
 
 
    
 
 
 
Modification
In October 2023, the Company’s board of directors approved an extension to the post-termination exercise period from three months to three years for certain option holders. The modification resulted in total incremental expense of $0.6 million, of which $0.3 million was recognized immediately as it related to vested awards, with the balance recognized over the remaining service periods.